IL196741A - Grain and tablets that break down in the mouth containing oxycodone - Google Patents
Grain and tablets that break down in the mouth containing oxycodoneInfo
- Publication number
- IL196741A IL196741A IL196741A IL19674109A IL196741A IL 196741 A IL196741 A IL 196741A IL 196741 A IL196741 A IL 196741A IL 19674109 A IL19674109 A IL 19674109A IL 196741 A IL196741 A IL 196741A
- Authority
- IL
- Israel
- Prior art keywords
- disinitegrating
- oxycodone
- orally
- granules
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82144906P | 2006-08-04 | 2006-08-04 | |
PCT/EP2007/057912 WO2008015220A1 (en) | 2006-08-04 | 2007-07-31 | Granule and orally disintegrating tablet comprising oxycodone |
Publications (2)
Publication Number | Publication Date |
---|---|
IL196741A0 IL196741A0 (en) | 2009-11-18 |
IL196741A true IL196741A (en) | 2015-05-31 |
Family
ID=38752477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL196741A IL196741A (en) | 2006-08-04 | 2009-01-27 | Grain and tablets that break down in the mouth containing oxycodone |
Country Status (15)
Country | Link |
---|---|
US (1) | US8465776B2 (ja) |
EP (1) | EP2046285B1 (ja) |
JP (1) | JP5421775B2 (ja) |
KR (1) | KR101445757B1 (ja) |
CN (1) | CN101534792B (ja) |
AU (1) | AU2007280470B2 (ja) |
BR (1) | BRPI0714514B8 (ja) |
CA (1) | CA2659122C (ja) |
EA (1) | EA017832B1 (ja) |
ES (1) | ES2667944T3 (ja) |
IL (1) | IL196741A (ja) |
MX (1) | MX2009001294A (ja) |
NZ (1) | NZ574544A (ja) |
WO (1) | WO2008015220A1 (ja) |
ZA (1) | ZA200900640B (ja) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
EP2957281A1 (en) | 2001-09-21 | 2015-12-23 | Egalet Ltd. | Polymer release system |
DE602004031096D1 (de) | 2003-03-26 | 2011-03-03 | Egalet As | Morphin-system mit kontrollierter freisetzung |
CA2659523C (en) * | 2006-08-04 | 2014-01-28 | Ethypharm | Multilayer orally disintegrating tablet |
CA2687192C (en) | 2007-06-04 | 2015-11-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
KR101682963B1 (ko) * | 2008-10-24 | 2016-12-06 | 도레이 카부시키가이샤 | 4,5-에폭시모르피난 유도체를 함유하는 안정한 정제 |
US9005660B2 (en) | 2009-02-06 | 2015-04-14 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
MX345942B (es) * | 2009-05-01 | 2017-02-27 | Adare Pharmaceuticals Inc | Composiciones de tabletas que se desintegran oralmente que comprenden combinaciones de farmacos en dosis alta y baja. |
WO2010149169A2 (en) | 2009-06-24 | 2010-12-29 | Egalet A/S | Controlled release formulations |
US20110150989A1 (en) * | 2009-12-22 | 2011-06-23 | Mallinkckrodt Inc. | Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
US9198861B2 (en) * | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US20130240384A1 (en) * | 2010-08-18 | 2013-09-19 | Purdue Pharma L.P. | Vacuum Avoiding Packaging Systems and Methods Thereof |
CN102178657B (zh) * | 2011-04-11 | 2017-05-31 | 浙江华海药业股份有限公司 | 一种奥氮平口腔崩解片 |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
US10688041B2 (en) | 2012-05-03 | 2020-06-23 | Kala Pharmaceuticals, Inc. | Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
JP6360039B2 (ja) | 2012-05-03 | 2018-07-18 | カラ ファーマシューティカルズ インコーポレイテッド | 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法 |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
CA2877183A1 (en) | 2012-07-06 | 2014-01-09 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
PL2872121T3 (pl) | 2012-07-12 | 2019-02-28 | SpecGx LLC | Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania |
KR101340733B1 (ko) * | 2012-12-31 | 2013-12-12 | (주) 에프엔지리서치 | 신규한 마이크로그래뉼 제형 |
EP2801349A1 (en) * | 2013-05-06 | 2014-11-12 | Siegfried AG | Oral Pharmaceutical Formulation |
CA2919892C (en) | 2013-08-12 | 2019-06-18 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US20150118300A1 (en) | 2013-10-31 | 2015-04-30 | Cima Labs Inc. | Immediate Release Abuse-Deterrent Granulated Dosage Forms |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
EP3169315B1 (en) | 2014-07-17 | 2020-06-24 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
AU2015336065A1 (en) | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
GR1008992B (el) | 2015-12-17 | 2017-03-23 | Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων | Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης |
JP6905972B2 (ja) * | 2016-02-23 | 2021-07-21 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
JP6915258B2 (ja) * | 2016-10-21 | 2021-08-04 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
KR102120720B1 (ko) * | 2018-07-16 | 2020-06-10 | 연성정밀화학(주) | 날푸라핀 함유 구강붕해정 |
CN109512796A (zh) * | 2018-12-26 | 2019-03-26 | 甘肃普安制药股份有限公司 | 一种氨酚羟考酮胶囊填充方法 |
EP3965733A4 (en) | 2019-05-07 | 2023-01-11 | Clexio Biosciences Ltd. | ABUSE DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
CN113842376A (zh) * | 2020-06-28 | 2021-12-28 | 齐鲁制药有限公司 | 一种含有利培酮的药物组合物和口溶膜剂及制备方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
US5286493A (en) * | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
CA2128820A1 (en) | 1993-07-27 | 1995-01-28 | Walter G. Gowan, Jr. | Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof |
EP1442745A1 (en) * | 1993-10-07 | 2004-08-04 | Euro-Celtique | Orally administrable opioid formulations having extended duration of effect |
US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
BR9908438A (pt) | 1998-03-06 | 2000-10-31 | Eurand Int | Tabletes de desintegração rápida |
SI1100469T1 (ja) * | 1998-07-28 | 2005-08-31 | Takeda Pharmaceutical | |
FR2785538B1 (fr) | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
CA2351720C (en) * | 1998-11-25 | 2006-11-21 | Cima Labs Inc. | Taste masking rapid release coating system |
US6740341B1 (en) * | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
DK1416842T3 (da) | 2001-07-18 | 2009-03-16 | Euro Celtique Sa | Farmaceutiske kombinationer af oxycodon og naloxon |
US20030044458A1 (en) * | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
CA2478558C (en) * | 2002-03-14 | 2012-09-11 | Euro-Celtique, S.A. | Naltrexone hydrochloride compositions |
FR2850576B1 (fr) | 2003-02-05 | 2007-03-23 | Ethypharm Sa | Composition comprenant un melange de principes actifs, et procede de preparation |
WO2006127879A1 (en) * | 2005-05-26 | 2006-11-30 | Duramed Pharmaceuticals, Inc. | Flexible solid dosage forms and methods of making and using the same |
WO2007063552A1 (en) * | 2005-12-02 | 2007-06-07 | Lupin Limited | Stable taste masked formulations of cephalosporins |
CA2659523C (en) * | 2006-08-04 | 2014-01-28 | Ethypharm | Multilayer orally disintegrating tablet |
-
2007
- 2007-07-31 CN CN2007800363003A patent/CN101534792B/zh active Active
- 2007-07-31 BR BRPI0714514A patent/BRPI0714514B8/pt active IP Right Grant
- 2007-07-31 WO PCT/EP2007/057912 patent/WO2008015220A1/en active Application Filing
- 2007-07-31 ES ES07788099.5T patent/ES2667944T3/es active Active
- 2007-07-31 ZA ZA200900640A patent/ZA200900640B/xx unknown
- 2007-07-31 EA EA200900260A patent/EA017832B1/ru not_active IP Right Cessation
- 2007-07-31 KR KR1020097002243A patent/KR101445757B1/ko active IP Right Grant
- 2007-07-31 US US12/376,060 patent/US8465776B2/en active Active
- 2007-07-31 AU AU2007280470A patent/AU2007280470B2/en active Active
- 2007-07-31 CA CA2659122A patent/CA2659122C/en active Active
- 2007-07-31 NZ NZ574544A patent/NZ574544A/en unknown
- 2007-07-31 JP JP2009522247A patent/JP5421775B2/ja active Active
- 2007-07-31 EP EP07788099.5A patent/EP2046285B1/en active Active
- 2007-07-31 MX MX2009001294A patent/MX2009001294A/es active IP Right Grant
-
2009
- 2009-01-27 IL IL196741A patent/IL196741A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN101534792B (zh) | 2013-02-20 |
EA200900260A1 (ru) | 2009-06-30 |
JP5421775B2 (ja) | 2014-02-19 |
WO2008015220A8 (en) | 2008-04-03 |
NZ574544A (en) | 2011-12-22 |
MX2009001294A (es) | 2009-05-21 |
BRPI0714514B8 (pt) | 2021-05-25 |
US20090304792A1 (en) | 2009-12-10 |
EP2046285A1 (en) | 2009-04-15 |
EA017832B1 (ru) | 2013-03-29 |
IL196741A0 (en) | 2009-11-18 |
JP2009545560A (ja) | 2009-12-24 |
BRPI0714514B1 (pt) | 2020-01-07 |
KR20090034372A (ko) | 2009-04-07 |
CA2659122A1 (en) | 2008-02-07 |
CA2659122C (en) | 2016-08-23 |
KR101445757B1 (ko) | 2014-10-02 |
AU2007280470A1 (en) | 2008-02-07 |
WO2008015220A1 (en) | 2008-02-07 |
AU2007280470B2 (en) | 2013-03-14 |
EP2046285B1 (en) | 2018-02-21 |
US8465776B2 (en) | 2013-06-18 |
BRPI0714514A2 (pt) | 2013-07-02 |
ES2667944T3 (es) | 2018-05-16 |
ZA200900640B (en) | 2010-06-30 |
CN101534792A (zh) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL196741A (en) | Grain and tablets that break down in the mouth containing oxycodone | |
GB2456989B (en) | Granules, tablets and granulation | |
IL194355A0 (en) | Orally disintegrating tablets | |
EP2084519A4 (en) | ADVANCED PRODUCTION AND MANUFACTURE OF MEDICINES | |
ZA200810323B (en) | Fkbp-l and uses thereof | |
IL194751A0 (en) | Drugs and uses | |
SI2064327T1 (sl) | DBAIT in njegova uporaba | |
EP1905430A4 (en) | TABLET | |
GB0621160D0 (en) | Compounds and uses thereof | |
IL194899A0 (en) | Amino-ethyl-amino-aryl (aeaa) compounds and their use | |
HK1133552A1 (en) | Carboranylporphyrins and uses thereof | |
ZA200807614B (en) | Buprenorphine derivatives and uses thereof | |
SI2040684T1 (sl) | Večenotne tablete | |
EP2124908A4 (en) | CONNECTIONS AND ITS USE | |
ZA200904654B (en) | Tablet formulation | |
GB0424323D0 (en) | Tablet | |
EP2069371A4 (en) | ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE | |
EP2120563A4 (en) | CONNECTIONS AND ITS USES | |
EP2099459A4 (en) | COMPOUNDS AND USES THEREOF | |
PT1867324T (pt) | Comprimido¿ | |
GB0614871D0 (en) | Proximity activated camera | |
ZA200902712B (en) | Granules, tablets and granulation | |
EP2050456A4 (en) | COMPRESSED | |
SI2046300T1 (sl) | Veäśplastna tableta, ki se razpusti v ustih | |
EP2120957A4 (en) | COMPOUNDS AND USES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |